Improved protein-ligand docking using GOLD

Proteins: Structure, Function and Genetics

Volumn 52, Issue 4, 2003, Pages 609-623

  Verdonk, Marcel L ^a   Cole, Jason C ^b   Hartshorn, Michael J ^a   Murray, Christopher W ^a   Taylor, Richard D ^a  

^a ASTEX PHARMACEUTICALS   (United Kingdom)

^b CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE   (United Kingdom)

Author keywords

Binding affinity; Binding mode; Chemscore; Consensus docking; Scoring functions; Virtual screening

Indexed keywords

LIGAND; PROTEIN;

ACCURACY; ARTICLE; BINDING AFFINITY; COMPUTER PROGRAM; ENERGY; INTERMETHOD COMPARISON; PERFORMANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SCORING SYSTEM; SCREENING;

ALGORITHMS; BINDING SITES; BINDING, COMPETITIVE; DATABASES, PROTEIN; DRUG DESIGN; HYDROGEN BONDING; LIGANDS; PROTEIN BINDING; PROTEINS; THERMODYNAMICS;

EID: 0041919542     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.10465     Document Type: Article

References (30)

1. Makino S, Kuntz ID. Automated flexible ligand docking method and its application for database search. J Comput Chem 1997;18:1812-1825.
2. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996;261:470-489.
3. Baxter CA, Murray CW, Clark DE, Westhead DR, Eldridge MD. Flexible docking using Tabu search and an empirical estimate of binding affinity. Proteins 1998;33:367-382.
4. Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727-748.
5. Jones G, Willett P, Glen RC. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 1995;245:43-53.
6. Taylor RD, Jewsbury PJ, Essex JW. A review of protein-small molecule docking methods. J Comput-Aided Mol Des 2002;16:151-166.
7. Nissink JWM, Murray CW, Hartshorn MJ, Verdonk ML, Cole JC, Taylor R. A new test set for validating predictions of protein-ligand interaction. Proteins 2002;49:457-471.
8. Baxter CA, Murray CW, Waszkowycz B, Li J, Sykes RA, Bone RGA, Perkins TDJ, Wylie W. New approach to molecular docking and its application to virtual screening of chemical databases. J Chem Inf Comput Sci 2000;40:254-262.
9. Kramer B, Rarey M, Lengauer T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 1999;37:228-241.
10. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000;28:235-242.
11. Bohm HJ. The development of a simple empirical scoring function to estimate the binding constant for a protein ligand complex of known 3-dimensional structure. J Comput-Aided Mol Des 1994;8:243-256.
12. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Empirical scoring functions: 1. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput-Aided Mol Des 1997;11:425-445.
13. Verkhivker GM, Bouzida D, Gehlhaar DK, Rejto PA, Arthurs S, Colson AB, Freer ST, Larson V, Luty BA, Marrone T, Rose PW. Deciphering common failures in molecular docking of ligand-protein complexes. J Comput-Aided Mol Des 2000;14:731-751.
14. Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235-249.
15. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26.
16. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-2623.
17. Blundell TL, Jhoti H, Abell C. High-throughput crystallography for lead discovery in drug design. Nat Rev Drug Discov 2002;1:45-54.
18. Nienaber VL, Richardson PL, Klighofer V, Bouska JJ, Giranda VL, Greer J. Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat Biotechnol 2000;18:1105-1108.
19. Hajduk PJ, Meadows RP, Fesik SW. NMR-based screening in drug discovery. Q Rev Biophys 1999;32:211-240.
20. Fejzo J, Lepre CA, Peng JW, Bemis GW,Ajay, Murcko MA, Moore JM. The SHAPES strategy: An NMR-based approach for lead generation in drug discovery. Chem Biol 1999;6:755-769.
21. Boehm HJ, Boehringer M, Bur D, Gmuender H, Huber W, Klaus W, Kostrewa D, Kuehne H, Luebbers T, Meunier-Keller N, Mueller F. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization: A promising alternative to random screening. J Med Chem 2000;43:2664-2674.
22. Carr R, Jhoti H. Structure-based screening of low-affinity compounds. Drug Discov Today 2002;7:522-527.
23. Birch L, Murray CW, Hartshorn MJ, Tickle I, Verdonk ML. Sensitivity of molecular docking to induced f[t effects in influenza virus neuraminidase. J Comput-Aided Mol Des 2002;16:855-869.
24. Charifson PS, Corkery JJ, Murcko MA, Walters WP. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 1999;42:5100-5109.
25. Paul N, Rognan D. ConsDock: A new program for the consensus analysis of protein-ligand interactions. Proteins 2002;47:521-533.
26. Clark RD, Strizhev A, Leonard JM, Blake JF, Matthew JB. Consensus scoring for ligand/protein interactions. J Mol Graph Model 2002;20:281-295.
27. Terp GE, Johansen BN, Christensen IT, Jorgensen FS. A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. J Med Chem 2001;44:2333-2343.
28. Hoffmann D, Kramer B, Washio T, Steinmetzer T, Rarey M, Lengauer T. Two-stage method for protein-ligand docking. J Med Chem 1999;42:4422-4433.
29. Gohlke H, Hendlich M, Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol 2000;295:337-356.
30. Lyne PD. Structure-based virtual screening: An overview. Drug Discov Today 2002;7:1047-1055.